Palo Alto Investors LP Long-Term Concentrated

Location: Palo Alto, CA

CIK: 0001306923 · Show all filings

Period: Q3 2019 (← Previous) (Next →)

Filing Date: Nov 14, 2019

Total Value: $1.501B (100.0% shares, 0.0% debt)

Holdings (37)

BMRN BIOMARIN PHARMACEUTICAL INC 9.9%
Value $149M Shares 2,209,504 Est. Cost $80.19 Unrealized -3.9%
INSM INSMED INC 8.5%
Value $128M Shares 7,239,649 Est. Cost $17.16 Unrealized +12.5%
ABIOMED INC 7.8%
Value $116M Shares 654,428 Est. Cost $37.80 Unrealized
UTHR UNITED THERAPEUTICS CORP 7.6%
Value $114M Shares 1,424,401 Est. Cost $88.73 Unrealized -9.2%
STAA STAAR SURGICAL CO 6.7%
Value $100M Shares 3,890,693 Est. Cost $13.06 Unrealized +132.7%
SAGE THERAPEUTICS INC 6.4%
Value $95.52M Shares 680,894 Est. Cost $48.62 Unrealized
ALEXION PHARMACEUTICALS INC 6.2%
Value $93.82M Shares 957,950 Est. Cost $121.54 Unrealized
IMMUNOMEDICS INC 5.5%
Value $82M Shares 6,184,320 Est. Cost $13.38 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 5.2%
Value $78.34M Shares 2,176,677 Est. Cost $27.34 Unrealized +10.9%
AIMMUNE THERAPEUTICS INC 4.8%
Value $72.7M Shares 3,471,740 Est. Cost $22.84 Unrealized
EPIZYME INC 4.4%
Value $65.55M Shares 6,354,659 Est. Cost $15.12 Unrealized
VNDA VANDA PHARMACEUTICALS INC 4.1%
Value $60.84M Shares 4,581,176 Est. Cost $11.21 Unrealized +24.3%
FOLD AMICUS THERAPEUTICS INC 3.8%
Value $57.45M Shares 7,162,920 Est. Cost $7.54 Unrealized +44.0%
WRIGHT MEDICAL GROUP NV 3.4%
Value $51.46M Shares 2,494,255 Est. Cost $23.42 Unrealized
KARYOPHARM THERAPEUTICS INC 3.1%
Value $46.58M Shares 4,842,150 Est. Cost $17.42 Unrealized
AMAG PHARMACEUTICALS INC 2.4%
Value $35.56M Shares 3,078,874 Est. Cost $29.07 Unrealized
ALDER BIOPHARMACEUTICALS INC 2.3%
Value $35.11M Shares 1,861,630 Est. Cost $11.48 Unrealized
ALGN ALIGN TECHNOLOGY INC 1.8%
Value $26.69M Shares 147,505 Est. Cost $114.31 Unrealized +81.9%
MOMENTA PHARMACEUTICALS INC 1.5%
Value $22.77M Shares 1,757,122 Est. Cost $14.06 Unrealized
CLOVIS ONCOLOGY INC 1.2%
Value $18.55M Shares 4,720,744 Est. Cost $51.30 Unrealized
PBYI PUMA BIOTECHNOLOGY INC 1.0%
Value $15.13M Shares 1,405,680 Est. Cost $28.90 Unrealized -62.6%
PRTA PROTHENA CORP PLC 0.5%
Value $7.875M Shares 1,004,449 Est. Cost $32.98 Unrealized -73.1%
RIGEL PHARMACEUTICALS INC 0.4%
Value $6.708M Shares 3,587,351 Est. Cost $3.40 Unrealized
KLDO KALEIDO BIOSCIENCES INC 0.4%
Value $5.934M Shares 787,999 Est. Cost $13.76 Unrealized -36.9%
DICERNA PHARMACEUTICALS INC 0.3%
Value $4.765M Shares 331,813 Est. Cost $5.39 Unrealized
GILD GILEAD SCIENCES INC 0.2%
Value $2.491M Shares 39,300 Est. Cost $62.02 Unrealized -17.8%
CELGENE CORP 0.1%
Value $2.173M Shares 21,883 Est. Cost $89.02 Unrealized
ALIMERA SCIENCES INC 0.1%
Value $1.707M Shares 3,013,793 Est. Cost $4.88 Unrealized
CYTK CYTOKINETICS INC 0.1%
Value $1.408M Shares 123,686 Est. Cost $6.71 Unrealized +87.0%
ZOGENIX INC 0.1%
Value $1.181M Shares 29,500 Est. Cost $13.36 Unrealized
SUNESIS PHARMACEUTICALS INC 0.1%
Value $837K Shares 1,162,473 Est. Cost $4.37 Unrealized
ALDX ALDEYRA THERAPEUTICS INC 0.0%
Value $387K Shares 73,500 Est. Cost $7.53 Unrealized -28.5%
MINERVA NEUROSCIENCES INC 0.0%
Value $281K Shares 36,319 Est. Cost $5.62 Unrealized
IDERA PHARMACEUTICALS INC 0.0%
Value $223K Shares 77,044 Est. Cost $8.90 Unrealized
MARINUS PHARMACEUTICALS INC 0.0%
Value $193K Shares 125,321 Est. Cost $4.17 Unrealized
SOPHIRIS BIO INC 0.0%
Value $144K Shares 247,000 Est. Cost $2.60 Unrealized
MELINTA THERAPEUTICS INC 0.0%
Value $39,000 Shares 10,137 Est. Cost $3.55 Unrealized